International Journal of Cardiology Cardiovascular Risk and Prevention最新文献

{"title":"Registry study of cardiovascular death in Sweden 2013–2019: Home as place of death and specialized palliative care are the preserve of a minority","authors":"Stina Nyblom ,&nbsp;Joakim Öhlén ,&nbsp;Cecilia Larsdotter ,&nbsp;Anneli Ozanne ,&nbsp;Carl Johan Fürst ,&nbsp;Ragnhild Hedman","doi":"10.1016/j.ijcrp.2024.200328","DOIUrl":"10.1016/j.ijcrp.2024.200328","url":null,"abstract":"<div><h3>Background</h3><p>Palliative care needs in patients with cardiovascular diseases (CVD) are expected to increase. For the planning of equitable palliative care, it is important to understand where people with CVD die. The aim was to examine trends in place of death, associated factors including utilization of specialized palliative services, and to what extent longitudinal development is influenced by national policy.</p></div><div><h3>Methods</h3><p>A population-level registry study of place of death for adults deceased due to CVD (n = 209 671) in Sweden 2013–2019. Linear regression analysis was applied.</p></div><div><h3>Results</h3><p>The predominant place of death was nursing home (39.1 %) and hospital (37.6 %), followed by home (22.0 %). From 2013 to 2019 home deaths increased by 2.8 % and hospital deaths decreased by 3.0 %. An overall downward trend was found for dying in hospital compared to dying at home. With variations, this trend was seen in all healthcare regions and for all CVD types, except Stockholm and cerebrovascular disease, with no significant trend. Overall, but with cross-regional variations, 2.1 % utilized specialized palliative services, while 94.2 % had potential palliative care needs. Other variables significantly influencing the trend were age and having had an unplanned healthcare visit.</p></div><div><h3>Conclusion</h3><p>Despite a slight positive trend, only a minority of people with CVD die in their own home. Regional variations in place of death and the low and varied utilization of specialized palliative services indicate inequity in access to palliative care. Hence, the impact of current national policies is questionable and calls for strengthening through inclusion of early palliative care in specific CVD policies.</p></div>","PeriodicalId":29726,"journal":{"name":"International Journal of Cardiology Cardiovascular Risk and Prevention","volume":"23 ","pages":"Article 200328"},"PeriodicalIF":1.9,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S277248752400093X/pdfft?md5=8d1035ae7c457452c162d19d3210bc6a&pid=1-s2.0-S277248752400093X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142130173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Recovery of left ventricular function after surgery for aortic and mitral regurgitation with heart failure","authors":"Wei-Tsung Lai ,&nbsp;I-Chen Chen ,&nbsp;Ming-Chon Hsiung ,&nbsp;Ting-Chao Lin ,&nbsp;Kuan-Chih Huang ,&nbsp;Chung-Yi Chang ,&nbsp;Jeng Wei","doi":"10.1016/j.ijcrp.2024.200329","DOIUrl":"10.1016/j.ijcrp.2024.200329","url":null,"abstract":"<div><h3>Background</h3><p>Severe aortic regurgitation (AR) and mitral regurgitation (MR) can lead to left ventricular (LV) systolic dysfunction; however, there are limited data about recovery of LV after surgery for AR or MR. Little is known to guide the management of combined AR and MR (mixed valvular heart disease [VHD]). This study is sought to investigate the predictors of postoperative LV function recovery in left-sided regurgitant VHD with reduced left ventricular ejection fraction (LVEF), especially for mixed VHD.</p></div><div><h3>Methods</h3><p>From 2010 to 2020, 2053 adult patients underwent aortic or mitral valve surgery at our center. The patients with valvular stenosis, infective endocarditis, concomitant revascularization, and preoperative LVEF ≥40 % were excluded. A total of 127 patients were included in this study: 22 patients with predominant AR (AR group), 64 with predominant MR (MR group), and 41 with combined AR and MR (AMR group).</p></div><div><h3>Results</h3><p>The mean preoperative LVEF was 32.4 %, 30.7 %, and 30.2 % (p = 0.44) in the AR, MR, and AMR groups, respectively. The AR group was more likely to have postoperative LVEF recovery. The cut-point of left ventricular end-systolic diameter (LVESD) for better recovery was 49 mm for the MR group and 58 mm for the AMR group.</p></div><div><h3>Conclusion</h3><p>LV dysfunction due to combined AR and MR has similar remodeling reserve as AR, and better recoverability than MR. Thus, double-valve surgery is recommended before the LVESD is &gt; 58 mm.</p></div>","PeriodicalId":29726,"journal":{"name":"International Journal of Cardiology Cardiovascular Risk and Prevention","volume":"23 ","pages":"Article 200329"},"PeriodicalIF":1.9,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772487524000941/pdfft?md5=8423d537bbd958f875a3fa60fe985bbe&pid=1-s2.0-S2772487524000941-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142151815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Demographic trends and disparities in mortality related to coexisting heart failure and diabetes mellitus among older adults in the United States between 1999 and 2020: A retrospective population-based cohort study from the CDC WONDER database","authors":"Humza Saeed ,&nbsp;M.B.B.S. Abdullah ,&nbsp;Irum Naeem ,&nbsp;Amna Zafar ,&nbsp;Bilal Ahmad ,&nbsp;Taimur ul Islam ,&nbsp;Syed Saaid Rizvi ,&nbsp;Nikita Kumari ,&nbsp;Syed Ghazi Ali Kirmani ,&nbsp;Fatima Mansoor ,&nbsp;Amir Hassan ,&nbsp;Adarsh Raja ,&nbsp;Mohamed Daoud ,&nbsp;Aman Goyal","doi":"10.1016/j.ijcrp.2024.200326","DOIUrl":"10.1016/j.ijcrp.2024.200326","url":null,"abstract":"<div><h3>Background</h3><p>Heart Failure (HF) and Diabetes Mellitus (DM) often coexist, and each condition independently increases the likelihood of developing the other. While there has been concern regarding the increasing burden of disease for both conditions individually over the last decade, a comprehensive examination of mortality trends and demographic and regional disparities needs to be thoroughly explored in the United States (US).</p></div><div><h3>Methods</h3><p>This study analyzed death certificates from the CDC WONDER database, focusing on mortality caused by the co-occurrence of HF and DM in adults aged 75 and older from 1999 to 2020. Age-adjusted mortality rates (AAMRs) and annual percent changes (APCs) were computed and categorized by year, gender, race, census region, state, and metropolitan status.</p></div><div><h3>Results</h3><p>A total of 663,016 deaths were reported in patients with coexisting HF and DM. Overall, AAMR increased from 154.1 to 186.1 per 100,000 population between 1999 and 2020, with a notable significant increase from 2018 to 2020 (APC: 11.30). Older men had consistently higher AAMRs than older women (185 vs. 135.4). Furthermore, we found that AAMRs were highest among non-Hispanic (NH) American Indian or Alaskan natives and lowest in NH Asian or Pacific Islanders (214.4 vs. 104.1). Similarly, AAMRs were highest in the Midwestern region and among those dwelling in non-metropolitan areas.</p></div><div><h3>Conclusions</h3><p>Mortality from HF and DM has risen significantly in recent years, especially among older men, NH American Indian or Alaska Natives, and those in non-metropolitan areas. Urgent policies need to be developed to address these disparities and promote equitable healthcare access.</p></div>","PeriodicalId":29726,"journal":{"name":"International Journal of Cardiology Cardiovascular Risk and Prevention","volume":"23 ","pages":"Article 200326"},"PeriodicalIF":1.9,"publicationDate":"2024-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772487524000916/pdfft?md5=03b9d9e7d77ad69223a8ed7c5632e802&pid=1-s2.0-S2772487524000916-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142076763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hypertension risk perception among young adults in Victoria University Kampala Uganda","authors":"Grace Afam ,&nbsp;Annet Patience Nakalega","doi":"10.1016/j.ijcrp.2024.200327","DOIUrl":"10.1016/j.ijcrp.2024.200327","url":null,"abstract":"<div><h3>Introduction</h3><p>Globally, hypertension is becoming a more serious public health concern, with young adults also at risk. Effective intervention techniques require an understanding of young adults' perceptions of the risk factors, enablers, and barriers to adopting healthy lifestyle choices related to hypertension. This research aims to examine hypertension risk perception among young adults at Victoria University Kampala, Uganda.</p></div><div><h3>Methods</h3><p>Data were gathered using a structured questionnaire between November 2023 and January 2024. Convenience sampling was used to gather data from young adults at Victoria University Kampala, Uganda. Leslie Kish's formula was used to establish the sample size of 126 respondents. Multiple regression analysis was performed to examine the association between independent variables (barriers, and facilitators) and the dependent variable (perception of hypertension risk).</p></div><div><h3>Results</h3><p>The study found that perceptions of certain risk factors, such as smoking (OR = 2.418, p = 0.035), physical inactivity (OR = 1.731, p = 0.008), unhealthy diet (OR = 2.174, p = 0.048), and chronic stress (OR = 1.514, p = 0.028), significantly influenced the likelihood of adopting healthy lifestyle choices. Among the enablers, motivation (OR = 3.491, p = 0.005), availability of time (OR = 3.015, p = 0.011), financial resources (OR = 2.164, p = 0.017), and social support (OR = 2.014, p = 0.026) were strong predictors of healthy behaviour adoption.</p></div><div><h3>Conclusion</h3><p>Programs aimed at raising awareness of hypertension risk factors and enhancing enablers such as motivation, time management, and social support are recommended to effectively promote healthy behaviours among this population.</p></div>","PeriodicalId":29726,"journal":{"name":"International Journal of Cardiology Cardiovascular Risk and Prevention","volume":"23 ","pages":"Article 200327"},"PeriodicalIF":1.9,"publicationDate":"2024-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772487524000928/pdfft?md5=ac5dc0b3862d21cfaa57805dfcfc6319&pid=1-s2.0-S2772487524000928-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142076764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Gene editing of angiotensin for blood pressure management","authors":"Stefano Masi ,&nbsp;Hermann Dalpiaz ,&nbsp;Claudio Borghi","doi":"10.1016/j.ijcrp.2024.200323","DOIUrl":"10.1016/j.ijcrp.2024.200323","url":null,"abstract":"<div><p>Arterial hypertension has remained the world's leading cause of morbidity and mortality for more than 20 years. While early Genome-Wide Association Studies raised the hypothesis that a precision medicine approach could be implemented in the treatment of hypertension, the large number of single nucleotide polymorphisms that were found to be associated with blood pressure and their limited impact on the blood pressure values have initially hampered these expectations. With the development and refinement of gene-editing and RNA-based approaches allowing selective and organ-specific modulation of critical systems involved in blood pressure regulation, a renewed interest in genetic treatments for hypertension has emerged. The CRISPR-Cas9 system, antisense oligonucleotides (ASO) and small interfering RNA (siRNA) have been used to specifically target the hepatic angiotensinogen (AGT) production, with the scope of safely but effectively reducing the activation of the renin-angiotensin system, ultimately leading to an effective reduction of the blood pressure with extremely simplified treatment regimens that involve weekly, monthly or even once-in-life injection of the drugs. Among the various approaches, siRNA and ASO that reduce hepatic AGT production are in advanced development, with phase I and II clinical trials showing their safety and effectiveness. In the current manuscript, we review the mode of action of these new approaches to hypertension treatment, discussing the results of the clinical trials and their potential to revolutionize the management of hypertension.</p></div>","PeriodicalId":29726,"journal":{"name":"International Journal of Cardiology Cardiovascular Risk and Prevention","volume":"23 ","pages":"Article 200323"},"PeriodicalIF":1.9,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772487524000886/pdfft?md5=f5c459350a17ccb4ac0136c6eff8f038&pid=1-s2.0-S2772487524000886-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142011380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of myocardial work and exercise capacity in patients recovered from the severe form of COVID-19","authors":"Thiago Lins Fagundes de Sousa ,&nbsp;Allan Robson Kluser Sales ,&nbsp;Juliana Góes Martins Fagundes ,&nbsp;Luis Fábio Barbosa Botelho ,&nbsp;Francis Ribeiro de Souza ,&nbsp;Guilherme Wesley Fonseca ,&nbsp;André Luis Pereira de Albuquerque ,&nbsp;Marcelo Dantas Tavares de Melo ,&nbsp;Maria-Janieire de Nazaré Nunes Alves","doi":"10.1016/j.ijcrp.2024.200324","DOIUrl":"10.1016/j.ijcrp.2024.200324","url":null,"abstract":"<div><h3>Background</h3><p>The impact of COVID-19 goes beyond its acute form and can lead to the persistence of symptoms and the emergence of systemic disorders, defined as long-term COVID.</p></div><div><h3>Methods</h3><p>We performed a cross-sectional study that included patients over 18 years of age who recovered from the severe form of COVID-19 at least 60 days after their discharge. Patients and controls were enrolled to undergo transthoracic echocardiography (TTE) using a more sensitive tool, myocardial work, in combination with cardiopulmonary exercise testing (CPET).</p></div><div><h3>Results</h3><p>A total of 52 patients and 31 controls were enrolled. Significant differences were observed in ejection fraction (LVEF; 62 ± 7 vs. 66 ± 6 %; p = 0.007), global longitudinal strain (LVGLS; −18.7 ± 2.6 vs. −20.4 ± 1.4 %; p = 0.001), myocardial wasted work (GWW; 152 ± 81 vs. 101 ± 54 mmHg; p = 0.003), and myocardial work efficiency (GWE; 93 ± 3 vs. 95 ± 2 %; p = 0.002). We found a significant difference in peak VO₂ (24.4 ± 5.4 vs. 33.4 ± 8.8 mL/kg/min; p &lt; 0.001), heart rate (160 ± 14 vs. 176 ± 11 bpm; p &lt; 0.001), ventilation (84.6 ± 22.6 vs. 104.9 ± 27.0 L/min; p &lt; 0.001), OUES% (89 ± 16 vs. 102 ± 22 %; p = 0.002), T ½ (120.3 ± 32 vs. 97.6 ± 27 s; p = 0.002) and HRR at 2 min (−36 ± 11 vs. −43 ± 13 bpm; p = 0.010).</p></div><div><h3>Conclusion</h3><p>Our findings revealed an increased wasted work, with lower myocardial efficiency, significantly reduced aerobic exercise capacity, and abnormal heart rate response during recovery, which may be related to previously described late symptoms. The reduction in functional capacity during physical exercise is partly associated with a decrease in resting myocardial work efficiency. These findings strongly indicate the need to determine whether these manifestations persist in the long term and their impact on cardiovascular health and quality of life in COVID-19 survivors.</p></div>","PeriodicalId":29726,"journal":{"name":"International Journal of Cardiology Cardiovascular Risk and Prevention","volume":"23 ","pages":"Article 200324"},"PeriodicalIF":1.9,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772487524000898/pdfft?md5=b916ffbd5011e23ab681a09d6aba116a&pid=1-s2.0-S2772487524000898-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142020595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Higher neighborhood disadvantage is associated with weaker interactions among cardiometabolic drivers","authors":"Joel Hernandez Sevillano ,&nbsp;Masih A. Babagoli ,&nbsp;Yitong Chen ,&nbsp;Shelley H. Liu ,&nbsp;Pranav Mellacheruvu ,&nbsp;Janet Johnson ,&nbsp;Borja Ibanez ,&nbsp;Oscar Lorenzo ,&nbsp;Jeffrey I. Mechanick","doi":"10.1016/j.ijcrp.2024.200322","DOIUrl":"10.1016/j.ijcrp.2024.200322","url":null,"abstract":"<div><h3>Background</h3><p>Adiposity, dysglycemia, and hypertension are metabolic drivers that have causal interactions with each other. However, the effect of neighborhood-level disadvantage on the intensity of interactions among these metabolic drivers has not been studied. The objective of this study is to determine whether the strength of the interplay between these drivers is affected by neighborhood-level disadvantage.</p></div><div><h3>Methods</h3><p>This cross-sectional study analyzed patients presenting to a multidisciplinary preventive cardiology center in New York City, from March 2017 to February 2021. Patients’ home addresses were mapped to the Area Deprivation Index to determine neighborhood disadvantage. The outcomes of interest were correlation coefficients (range from −1 to +1) among the various stages (0 - normal, 1 - risk, 2 - predisease, 3 - disease, and 4 - complications) of abnormal adiposity, dysglycemia, and hypertension at presentation, stratified by neighborhood disadvantage.</p></div><div><h3>Results</h3><p>The cohort consisted of 963 patients (age, median [IQR] 63.8 [49.7–72.5] years; 624 [65.1 %] female). The correlation among the various stages of adiposity, dysglycemia, and hypertension was weaker with increasing neighborhood disadvantage (P for trend &lt;0.001). Specifically, the correlation describing adiposity, dysglycemia, and hypertension interaction was weaker in the high neighborhood disadvantage group compared to the intermediate neighborhood disadvantage group (median [IQR]: 0.34 [0.27, 0.44] vs. median [IQR]: 0.39 [0.34, 0.45]; P &lt; 0.001) and compared to the low neighborhood disadvantage group (median [IQR]: 0.34 [0.27, 0.44] vs. median [IQR]: 0.54 [0.52, 0.57]; P &lt; 0.001), as well as weaker in the intermediate neighborhood disadvantage group compared to the low neighborhood disadvantage group (median [IQR]: 0.39 [0.34, 0.45] vs. 0.54 median [IQR]: 0.54 [0.52, 0.57]; P &lt; 0.001).</p></div><div><h3>Conclusions</h3><p>Interactions among the various stages of abnormal adiposity, dysglycemia, and hypertension with each other are weaker with increasing neighborhood disadvantage. Factors related to neighborhood-level disadvantage, other than abnormal adiposity, might play a crucial role in the development of dysglycemia and hypertension.</p></div>","PeriodicalId":29726,"journal":{"name":"International Journal of Cardiology Cardiovascular Risk and Prevention","volume":"23 ","pages":"Article 200322"},"PeriodicalIF":1.9,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772487524000874/pdfft?md5=cfe21e5ef0c759e4006c5ae46db78739&pid=1-s2.0-S2772487524000874-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142088993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Demographics and mortality trends of valvular heart disease in older adults in the United States: Insights from CDC-wonder database 1999–2019","authors":"Eman Ali ,&nbsp;Yusra Mashkoor ,&nbsp;Fakhar Latif ,&nbsp;Fnu Zafrullah ,&nbsp;Waleed Alruwaili ,&nbsp;Sameh Nassar ,&nbsp;Karthik Gonuguntla ,&nbsp;Harshith Thyagaturu ,&nbsp;Mohammad Kawsara ,&nbsp;Ramesh Daggubati ,&nbsp;Yasar Sattar ,&nbsp;Muhammad Sohaib Asghar","doi":"10.1016/j.ijcrp.2024.200321","DOIUrl":"10.1016/j.ijcrp.2024.200321","url":null,"abstract":"<div><h3>Background</h3><p>Valvular heart disease (VHD) represents a spectrum of cardiac conditions, including valvular stenosis, valvular regurgitation, or mixed lesions affecting single or multiple valves. The severity of VHD has emerged as a major cause of cardiovascular (CV) morbidity and mortality among the older population in the United States (U.S).</p></div><div><h3>Objective</h3><p>To evaluate temporal trends in mortality associated with VHD in the elderly U.S population between 1999 and 2019.</p></div><div><h3>Methods</h3><p>We utilized the CDC WONDER database for VHD mortality in adults ≥75 from 1999 to 2019, using ICD-10 codes. Age-adjusted mortality rates (AAMR) per 100,000 people with associated annual percentage change (APC) were calculated. Joinpoint regression was used to assess the overall trends and trends for demographic, geographic, and type of valvular disease subgroups.</p></div><div><h3>Results</h3><p>A total of 666,765 VHD deaths in older adults from 1999 to 2019 was identified, with an initial decline in AAMR until 2007 with an APC: 0.62, 95 % CI (−1.66-0.33), stability until 2014, and a significant decrease until 2019 (APC: 1.47, 95 % CI [-2.24-1.04], P &lt; 0.0001). Men consistently had higher AAMRs compared to women (overall AAMR men: 173.6; women: 138.2). The AAMRs were found to be highest in the White (166.5), followed by American Indian or Alaska Native population at (93.8) Hispanic or Latino at (80.7), Black or African American populations at (74.1) and lastly Asian or Pacific Islander (73.4). Non-metropolitan areas manifested higher AAMRs for deaths related to VHD than metropolitan areas (overall AAMRs 160.5 vs 149.5) respectively. State-wide AAMRs varied, with the highest in Vermont at 324.2 (95 % CI [313.0–335.4], P &lt; 0.0001) and the lowest in Mississippi at 88.0 (95 % CI [85.0–91.0], P &lt; 0.0001). Non-rheumatic and aortic valve disorders in adults ≥75 years had higher mortality rates compared to rheumatic or mitral valve conditions in those &lt;75 years.</p></div><div><h3>Conclusion</h3><p>Our study showed a decline in U.S. VHD mortality from 1999 to 2019 but found persistent disparities by gender, race, age, region, and VHD type. Targeted policies for prevention and early diagnosis are needed to address these inequalities.</p></div>","PeriodicalId":29726,"journal":{"name":"International Journal of Cardiology Cardiovascular Risk and Prevention","volume":"22 ","pages":"Article 200321"},"PeriodicalIF":1.9,"publicationDate":"2024-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772487524000862/pdfft?md5=9c4cd178129bd7a1000dde714733fd4c&pid=1-s2.0-S2772487524000862-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142006807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Toothache of cardiovascular origin","authors":"Shanezehra Siddiqui,&nbsp;Yamaan Adil","doi":"10.1016/j.ijcrp.2024.200320","DOIUrl":"10.1016/j.ijcrp.2024.200320","url":null,"abstract":"","PeriodicalId":29726,"journal":{"name":"International Journal of Cardiology Cardiovascular Risk and Prevention","volume":"22 ","pages":"Article 200320"},"PeriodicalIF":1.9,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772487524000850/pdfft?md5=4a16010874dde6a5698594cde78c7da6&pid=1-s2.0-S2772487524000850-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141998355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of cardiovascular risk factors and cardiac diseases on mortality in patients with moderate to severe ARDS: A retrospective cohort study","authors":"Arnaud Gacouin ,&nbsp;Pauline Guillot ,&nbsp;Flora Delamaire ,&nbsp;Alexia Le Corre ,&nbsp;Quentin Quelven ,&nbsp;Nicolas Terzi ,&nbsp;Jean Marc Tadié ,&nbsp;Adel Maamar","doi":"10.1016/j.ijcrp.2024.200318","DOIUrl":"10.1016/j.ijcrp.2024.200318","url":null,"abstract":"<div><h3>Background</h3><p>Histor<strong>y</strong> of coronary artery disease (CAD) and/or atrial fibrillation (AF) and/or valvular replacement (VR) are prevalent among patients admitted to intensive care units (ICUs). The impact of these conditions on outcomes in patients with acute respiratory distress syndrome (ARDS) remains insufficiently explored.</p></div><div><h3>Methods</h3><p>We performed a retrospective study on prospectively collected data from patients with ARDS and a PaO₂/FiO₂ ratio ≤150 mmHg. Patients were admitted between January 2006 and March 2022. We used multivariable logistic regression analysis. The primary outcome was 1-year mortality from admission to the ICU; secondary outcomes included mortality at 28 days and 90 days.</p></div><div><h3>Results</h3><p>Among 1.033 patients, 181 (17.5 %) had a history of CAD and/or AF and/or VR. History of CAD and/or AF and/or VR was independently associated with 1-year mortality (Odds-Ratio (OR) = 2.59, 95 % confidence interval (CI) 1.76–3.82, p &lt; 0.001), with mortality at 90 days (OR = 1.87, 95 % CI 1.27–2.76, p = 0.001), but not with mortality at 28 days (OR = 1.40, 95 % CI 0.93–2.11, p = 0.10). In sensitivity analyses, history of CAD and/or AF and/or VR remained independently associated with 1-year mortality in ICU survivors (OR = 3.58, 95 % CI = 2.41–7.82, p &lt; 0.001).</p></div><div><h3>Conclusions</h3><p>History of CAD and/or AF and/or VR was associated with mortality in ARDS. Prompt referral to cardiologists for comprehensive management post-ICU discharge may be warranted to optimize outcomes in this vulnerable population.</p></div>","PeriodicalId":29726,"journal":{"name":"International Journal of Cardiology Cardiovascular Risk and Prevention","volume":"22 ","pages":"Article 200318"},"PeriodicalIF":1.9,"publicationDate":"2024-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772487524000837/pdfft?md5=fae1bf66386575f1e714cb3701a1e3cb&pid=1-s2.0-S2772487524000837-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141984558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}